* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download genetics, health and disease
Oncogenomics wikipedia , lookup
Biology and consumer behaviour wikipedia , lookup
Human genome wikipedia , lookup
Non-coding DNA wikipedia , lookup
Gene therapy wikipedia , lookup
Genetic drift wikipedia , lookup
Cell-free fetal DNA wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Tay–Sachs disease wikipedia , lookup
Behavioural genetics wikipedia , lookup
Genome evolution wikipedia , lookup
Fetal origins hypothesis wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Quantitative trait locus wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Frameshift mutation wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Genome editing wikipedia , lookup
Point mutation wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Human genetic variation wikipedia , lookup
Population genetics wikipedia , lookup
Genetic engineering wikipedia , lookup
History of genetic engineering wikipedia , lookup
Genetic testing wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Medical genetics wikipedia , lookup
Designer baby wikipedia , lookup
Microevolution wikipedia , lookup
GENETICS, HEALTH AND DISEASE Our bodies are built from millions of cells, each of which contains the information for making and maintaining a human body. The full set of information, our genome, consists of around 25,000 individual genes that organise how our bodies grow and develop from a single fertilised egg. Genetics is the study of this biological information, and of how it is passed on from one generation to another (inheritance). Genes are not the only influence that affect human development and health: the environment interacts with genetic make-up to determine, for example, lifespan and susceptibility to disease as well as many behavioural characteristics. Only genetic information, however, is directly passed on from one generation to the next. The chemicals of life Genetic information is stored inside each cell of the body as deoxyribonucleic acid (DNA). The essential functions of cells are performed by proteins, which are also key components of cellular structure. DNA has two primary features: it is a code for directing the formation of proteins, and it is also reproducible. The special structure of DNA is essential for both these functions. DNA has a long helical "backbone" with nucleotide bases attached. The chain pairing of these bases forms the famous double-helix structure deduced by Watson and Crick. There are four different bases: adenine (A), cytosine (C), guanine (G) and thymine (T). Bases A and T bind together specifically and reversibly, as do bases G and C. Genes and chromosomes A sequence of DNA that contains the information to code for a protein is called a gene. Every cell contains a complete set of DNA instructions for making the human body; this is the genome. The human genome contains 3 billion base pairs and around 25,000 genes representing 1-2% of the total genome. The functions, if any, of most of the rest of the genome are not known. The protein-coding DNA of most genes is not a continuous stretch but is interrupted by non-coding sequences called introns. Genes also contain regulatory sequences that control whether and when that protein is made. Within the cell, DNA is wound up very tightly and packaged with proteins to form chromosomes. Corresponding chromosomes from different individuals of the same species in general carry the same sets of genes in the same order. The chromosomes always come in even numbers because they occur in pairs whose members are very similar to each other; one member of each pair is inherited from the mother and the other from the father, with the result that every individual has two copies of each gene. Humans have 23 pairs of similar (homologous) chromosomes. The two sex chromosomes (X and Y) differ significantly from each other, but the other (autosomal) chromosome pairs are nearly identical. Women have two X chromosomes, whilst men have one X and one Y chromosome. The set of chromosomes in a cell is known as the karyotype. Special staining techniques can be used to visualise the chromosomes; different chromosomes have characteristic sizes and Set of chromosomes (karyotype) from when stained show characteristic patterns of transverse bands. a human male. Gene expression In order to make use of the information stored in its DNA, a cell needs to express that information - that is, to produce the proteins encoded by the genes. Different types of cells (for example bone, liver and skin cells) contain exactly the same DNA, but they have different functional characteristics because they have expressed different sets of genes. 1 Mutation and variation A mutation is an alteration in the normal sequence of a DNA molecule, most commonly due to mistakes made by the cellular machinery that copies DNA but also as a result of environmental agents such as radiation or hazardous chemicals. Most mutations are repaired by the cell, but if not they may lead to loss or alteration of the function of the protein encoded by the DNA. The nature and size of mutations vary. Small-scale mutations change small numbers of bases, as few as a single base (called a point mutation). Such mutations usually affect only a single protein but can have drastic consequences. For example, a change to a single base can lead to the formation of a nonMutations in reproductive cells are passed on functional protein. Mutations outside the coding regions of to all of the offspring's body cells. genes can still affect protein production; for instance, they may occur in regulatory regions, causing inappropriate gene expression. Mutations in genes that encode DNA repair proteins may cause the cell to become errorprone, accumulating multiple mutations in its DNA. Large-scale mutations (also called chromosomal rearrangements) often cause severe problems; for example, large deletions may completely remove one or more genes, whilst large duplications may cause too much of a protein to be produced, which can make cells grow wrongly. Insertions and translocations, in which segments of DNA are transferred from one chromosome to another, can change the way genes are expressed. Some genetic diseases are inherited from a parent or parents who carry and pass on to their offspring a disease-associated mutation. The parents may themselves have the disease, or they may be unaffected but pass on a copy of the disease gene. Cystic fibrosis is always inherited in this way. Other genetic diseases may be caused by new mutations that occur in the parental reproductive cells, such that although the parents do not carry the disease mutation, their child does. An example of a genetic disease that can arise in this way is type 1 neurofibromatosis. Not all DNA alterations cause disease. Mutation provides the basis for evolution: genetic alterations that increase reproductive fitness (or at least do not decrease it) will tend to persist and spread in a population. Over time, all species have accumulated subtly different normal variants of a DNA sequence that explain why individuals in these species are not identical. This phenomenon is known as polymorphism. Human DNA varies at about 1 base in every 300; only some of this variation falls within genes (protein coding regions). Alleles, genotype and phenotype Different versions of the same gene at the same position on corresponding chromosomes are known as alleles; because Large-scale chromosomal mutations every individual has two sets of chromosomes, there are two alleles for every gene (one inherited from their mother and the other from their father). Some alleles are identical in their action but others produce quite different effects. For example, sickle-cell anaemia is caused by a variant allele of a haemoglobin gene. If someone has two copies of the same allele then they are said to be homozygous for that allele. If they have different alleles of that gene then they are heterozygous at that genetic locus. An individual who is homozygous will show the characteristic associated with that form of the gene. For example, a person with two copies of the ‘A’ allele encoding a particular blood protein has type A blood. A person who has one copy of the A allele and one of the ‘O’ allele also has the A blood 2 type; in this case the A trait is said to be dominant over the O trait and the O trait is said to be recessive. The set of alleles that a particular person has is known as their genotype. The AA A set of observable characteristics that they have is known as their phenotype. The phenotype is the result of the AO A interaction between the genotype and environmental factors; OO O gene-environment interactions affect almost all human characteristics, including susceptibility to disease. Sometimes the environmental effects are small, for example eye colour is largely determined by the genotype. Other characteristics of the phenotype, however, such as height and weight, depend more strongly on environmental factors, although the genotype also plays an important role. Genotype (alleles) Phenotype (blood group) Genetics and disease There are several thousand inherited diseases known to be associated with mutations in single genes. These diseases show simple patterns of inheritance and are known as monogenic (single-gene) or Mendelian disorders. Other genetic diseases are caused by larger-scale chromosomal alterations. Individually, genetic diseases caused by chromosomal alterations or single-gene mutations are rare, but collectively Some genetic variations have no effect, but others can lead to these disorders are relatively common, with a disease or increased susceptibility to a disease. combined birth prevalence of around 1-2%. In addition, susceptibility to many common diseases of middle and later life is known to have a genetic component. In these cases, the association between gene variants and disease is less clear-cut: more than one gene may be involved and the genes interact in complex ways with each other and with environmental and lifestyle factors to determine whether disease will develop. Recent advances in genetics and molecular biology have begun to elucidate both the genetic mutations underlying many single-gene diseases, and some of the genetic variants associated with susceptibility to some common diseases. Monogenic diseases For inherited monogenic diseases, if the genotypes of parents with respect to a disease-associated gene are known, then the possible genotypes of their children can be predicted. If the diseaseassociated allele is dominant, it prevails over a normal allele, such that disease will be present in all individuals with either one or two copies of the disease allele. The children of an affected parent with one dominant allele and a normal (a) Autosomal dominant disease (b) Autosomal recessive disease partner would therefore have a 50% chance of inheriting a disease allele, and Patterns of inheritance for single-gene disorders hence of having the disease. Examples of autosomal dominant disorders include Huntingdon’s disease and neurofibromatosis. If, however, the disease-associated allele is recessive, then the disease is only seen in individuals who do not have a normal allele. In these autosomal recessive disorders such as cystic fibrosis and Tay-Sachs disease, affected individuals have two copies of a diseaseassociated allele; individuals with only one disease allele are healthy, but are carriers of the disease. Haemophilia, Duchenne Muscular Dystrophy (DMD) and Fragile-X syndrome are examples of sex-linked genetic disorders. This means that the gene associated with the disease is on one of the sex chromsomes, almost invariably the X chromosome. Females have two X chromosomes, so a female with one normal and one (recessive) haemophilia or DMD mutant allele will be a normal carrier. The sons of a carrier mother and unaffected father have a 50% chance of carrying the mutant allele on their single X chromosome, and therefore of being affected. 3 Numbers of people with some single-gene and chromosomal diseases. Numbers are based on a typical health authority district with 3,000 births annually and a total population of 250,000; Non-recurrent genetic diseases such as Down syndrome are not included. Condition New cases No. living per year in patients in district district 1/3,000 1/8,000 1.0 0.4 18 8 14 6 162 50 1/1.000 3.0 55 43 330 1/500 6.0 394 355 2360 1/12,000 1/2,500 0.25 1.2 19 69 12 30 70 280 1/100,000 0.03 1.3 0.8 10 1/5,000 1.6 36 32 220 1/30,000 0.1 8 5 230 1/2,000 1/10,000 1/54,000 1.5 0.3 0.06 25 23 2 20 20 1.7 50 46 4 1/10,000 0.3 3 2 46 1/13,000 1/27,000 1/250 0.2 0.1 18 9 15 6 36 18 Birth frequency No. unrelated families No. relatives at > 1 in 10 risk of being affected or carriers Autosomal dominant disorders Huntington's chorea Familial polyposis coli Adult polycystic disease of kidneys Familial hypercholesterolemia Tuberous sclerosis Neurofibromatosis Von-Hippel Lindau disease Retinitis pigmentosa Bilateral retinoblastoma Myotonic dystrophy 1/7,000 Autosomal recessive disorders Cystic fibrosis Adrenal hyperplasia Friedreich's ataxia Spinal muscular atrophy Phenylketonuria Usher's syndrome Sickle cell disease in Afro-Caribbeans Thalassaemia in Cypriots in Indians in Pakistanis 1/140 1/1,000 1/300 Estimates: actual figures depend on ethnic characteristics of the population and uptake of screening and offer of prenatal diagnosis X-linked recessive disease Duchenne/Becker muscular dystrophy Haemophilia A and B X-linked retinitis pigmentosa Other X-linked eye disorders Fragile-X syndrome Other forms of X-L mental disorders 1/9,000 0.3 8 7 78 1/20,000 0.15 11 7 66 1/7,000 0.43 23 14 70 1/7,000 0.43 23 14 70 1/4,000 0.75 52 49 360 1/4,000 0.75 52 49 360 Unbalanced translocations 1/2,000 1.5 16 16 60 TOTAL 1/144 20.8 987 Chromosomal disorders 730 5056 Notes Birth frequency: many of these birth frequencies are changing, and those listed here refer to the most recent figures. For example, the birth frequency of Duchenne muscular dystrophy has fallen from 1 in 6,000 to 1 in 9,000 as a result of genetic counselling. The birth frequency of thalassaemia in Cypriots has fallen to 0, as a result of antenatal screening, prenatal diagnosis and the offer of selective termination of pregnancy. Data taken from: Royal College of Physicians of London. Purchasers’ guidelines to genetic services in the NHS. An aid to assessing the genetic services required by the resident population of an average health district. London Royal College of Physicians, 1991. 4 Chromosomal disorders Large-scale chromosomal alterations often arise due to errors during cell division during the formation of reproductive cells. Aneuploidy (the presence of an abnormal number of chromosomes) usually prevents normal embryonic development and often causes spontaneous abortion. Perhaps the best-known example of non-fatal aneuploidy is Down syndrome, which is caused by the presence of an additional copy of chromosome 21 (trisomy 21). Specific disorders are also associated with structural alterations of chromosomes. Cri du chat syndrome is caused by a deletion on chromosome 5. Disease may also result from duplication of chromosomal regions; Fragile-X Syndrome is caused by the presence of an abnormal number of sequence repeats (several hundred) in a region of the X chromosome. Trisomy 21 karyotype Single-gene subsets of common diseases Although most common diseases result from the combined effects of multiple genes interacting with environmental factors, there are sometimes families in which several family members are affected by the same disease, often at an early age, suggesting the existence of a single mutation that confers a high risk of disease. In these single-gene subsets of common disease, such as familial hypercholesterolaemia, genotype can be used with a fairly high degree of certainty to predict the development of disease (in this instance, cardiovascular disease). In general, single-gene subsets of common diseases account for a maximum of 510% of the total burden of each disease. Cancer Cancer is often described as a ‘genetic disease’, in the sense that it is caused by genetic alterations. It occurs when the DNA instructions in a cell are damaged or altered in such as way that the cell escapes the normal mechanisms that should control its behaviour. Such cells may multiply unchecked to form tumours and acquire the ability to migrate to, lodge and grow in distant sites of the body (metastasis). The genetic alternations that lead to cancerous behaviour are somatic mutations, however. That is, they occur in the somatic cells of the body rather than the sperm or egg cells so they are not passed on to the next generation. However there are some inherited mutations (that is, mutations that are present in all the cells of the body including the sex cells) that predispose people who carry them to developing cancer in a particular tissue or organ. The BRCA1 and BRCA2 mutations associated with a high risk of breast cancer fall into this category. Penetrance and expressivity In many (but not all) single-gene diseases, a person with a specific Variable penetrance – only some individuals Ovals represent individuals genotype is virtually certain to with the mutation develop the disease with the disease gene: develop the associated disease (phenotype), though its symptoms, Unaffected age of onset and severity may vary. The likelihood that a person Mildly affected Variable expressivity – individuals with the carrying a disease-associated mutation show different disease severity genotype will develop the disease is Moderately affected known as the penetrance of the Severely affected phenotype. Huntington's disease is virtually 100% penetrant. The Variable penetrance and expressivity– BRCA1 gene mutations associated only some individuals with the mutation develop the disease; disease severity varies. with breast and ovarian cancer are highly penetrant, but not completely so; estimates of the lifetime penetrance of these mutations vary from about 60-85%. Most of the genetic variants associated with susceptibility to multifactorial disease are thought to be common in the population (so they are generally described as polymorphisms rather than mutations), but of low 5 penetrance. Variations in penetrance are caused by the modifying effects of other genes and/or by environmental factors. Expressivity is another important concept in genetic disease, and refers to the degree to which a phenotype is expressed – individuals affected by a disease with variable expressivity will show different symptoms and disease severity. The human genome project Over the last 15 years, scientists across the world have worked out the complete sequence of the 3 billion nucleotides in human DNA. The aim now is to find all the genes and to work out what they do. This research is producing an enormous amount of information: high-powered computers and software are needed to store and analyse it. What the scientists have so far is a sort of ‘average’ sequence based on DNA from a small number of people. Now they are looking at larger numbers of people from different human populations and are trying to find the points in the sequence where humans vary from one another. Genetic testing A genetic test is a test to detect the presence or absence of, or alteration in, a particular gene, chromosome or gene product, in relation to a genetic disorder. This may involve DNA sequencing to identify disease-associated mutations, or examination of chromosomes (cytogenetic analysis). For example, cytogenetic analysis is used to identify trisomy 21 for diagnosis of Down’s Syndrome. Genetic testing may also include physical examinations or biochemical tests for specific proteins or markers that indicate the presence of abnormal genes. In the case of phenylketonuria, for example, the genetic test is based on the detection of elevated concentrations of the amino acid phenylalanine in a blood sample. Diagnostic genetic testing The aim of diagnostic genetic testing is to establish the presence of a specific genetic disease, often in infants or young children, and ideally so that appropriate treatment may be undertaken. For example, in an infant with wasted muscles and difficulty in walking, symptoms consistent with muscular dystrophy but which might also have another cause, a genetic test could be used to provide a definitive diagnosis. Antenatal diagnostic testing requires fetal cells to be obtained by chorionic villus sampling or amniocentesis. The purpose of antenatal testing is to provide the parents with information that they may choose to act on, for example, by preparing for the birth of a disabled child, or by electing to terminate the pregnancy. A couple who have previously given birth to a child with a recessive single-gene disorder may elect to undergo antenatal diagnostic testing in subsequent pregnancies. For some couples in this situation, termination of an affected pregnancy is unacceptable but they wish to avoid giving birth to another affected child. In some cases, the option of pre-implantation genetic diagnosis may be available. This procedure involves the creation of embryos by in vitro fertilisation and the removal of 1-2 cells from each embryo that are tested for the disease-causing genotype. Embryos that are unaffected by the genetic disease are used to establish a pregnancy. Carrier testing Couples or individuals who know that a genetic disease runs in their family, or is prevalent in the population to which they belong, may wish to know their risk of passing on the disease to their children. In populations originating from some Mediterranean areas, for example, the single-gene autosomal recessive disease beta-thalassemia is relatively common. Couples may elect to undergo genetic testing to determine whether they are carriers of the disease-causing allele. Other examples of diseases for which carrier testing is sometimes used are cystic fibrosis (most common in Caucasian populations), sickle-cell anaemia (mostly in people of African origin), thalassaemia (populations from Asia and the Mediterranean) and Tay-Sachs disease (in Ashkenazic Jews). Newborn screening In the UK, blood samples from newborn babies are routinely screened to detect rare genetic diseases for which early intervention can avert serious health problems or death. Phenylketonuria (PKU), a metabolic disease that causes severe mental retardation if undetected but which can be prevented by a special low 6 phenylalanine diet, has been screened for since 1969. National newborn screening programmes for cystic fibrosis and sickle-cell disease are being introduced. There is no cure for cystic fibrosis but early diagnosis and treatment is thought to benefit the health of affected children. Screening for sickle-cell anaemia allows early diagnosis and prophylactic treatment with antibiotics and vaccines to prevent infection. Predictive genetic testing Predictive genetic testing (also known as pre-symptomatic testing) is the use of genetic testing to predict whether an individual will develop a genetic disease. It can only be used where the disease-associated mutation is known and is highly penetrant, for example in Huntington’s disease. As this is a late-onset disease, a person with a parent affected by the disease will not know whether he or she has inherited it until he or she reaches middle age. However, DNA testing will reveal whether the mutation is present, changing that person’s individual risk from 50% to either 100% or zero. Ideally, predictive genetic testing is used in association with prophylactic treatment for individuals who test positive. However, Huntington's disease is untreatable and fatal, so careful counselling is essential for any person from an affected family who is contemplating undergoing genetic testing. Testing for genetic susceptibility As genetic research advances, genetic variants are being identified that appear to be associated with increased or decreased risk of particular diseases. An example is the APOE4 allele of the gene encoding a blood protein called APOE, which is associated with an increased risk of Alzheimer’s disease. However, the presence of an E4 allele is neither necessary nor sufficient for a person to develop Alzheimer’s, so a genetic test for this allele, although technically straightforward, has limited predictive value. The clinical usefulness of such as test is also low, as there is currently no effective treatment or prophylaxis for the disease. In the future genetic susceptibility testing may find a place in mainstream clinical medicine, probably as part of an overall risk assessment that would include environmental and lifestyle factors. Any genetic tests used as part of such as assessment would need careful evaluation of their accuracy and clinical usefulness. A new era for medicine? Genetic scientists hope that once we know more about how the genetic programme works, both in healthy cells and as a disease develops, we may have new ideas about how diseases can be treated or prevented. Research on the human genome may lead to a new approach to medicine, where individual genetic factors can be taken into account when working out a person’s risk of disease and, if they become unwell, deciding on treatment tailored to that individual. For example, it is known that individuals can respond in very different ways to the same medicine: in one person it may work well, in another it may have no effect, while another again may experience a serious side-effect. Some of this variation in response to medicines is genetic. Research in pharmacogenetics seeks to identify important gene variants for each drug, with a view to developing pharmacogenetic tests for use before prescription of drugs; testing which genetic variants a person has could tell doctors what drug and what dose would be best for that individual. Genetics and society Some of these developments in medicine are still a long way off – probably several decades – but it is not too early to start thinking about the impact they may have on our lives. Everyone in society needs to be involved in this debate. Many possible dangers have been suggested, such as discrimination against people with a particular genetic make-up, or attempts to produce ‘designer babies’. In debating these issues, we must always keep in mind that although genes play an important part in determining ‘who we are’, they are by no means the whole story. We must avoid both unrealistic expectations from advances in genetics, and unrealistic fears. 7 Further information (on-line resources) • Public Health Genetics Unit – news and information about advances in genetics and their impact on public health and the prevention of disease. Information resource page provides information about the genetic basis of selected diseases. http://www.phgu.org.uk • National Human Genome Research Institute – information about genetics, inherited disease research and the future of health and genetics research. http://www.genome.gov/Health/ • Wellcome Trust Sanger Institute ‘Your Genome’ site - information about genome science. http://www.yourgenome.org • DNA from the beginning - animated tutorial from the DNA Learning Centre in Cold Spring Harbor. http://www.dnaftb.org/dnaftb/index.html • Medicine and the new genetics – medical genetics information from the US Department of Energy human genome website, including gene testing and genetic counselling. http://www.ornl.gov/TechResources/Human_Genome/medicine/medicine.html • GeneTests medical genetics information resource – includes GeneReviews, genetic disease profiles. http://www.geneclinics.org • Genes and Disease - collection of articles that discuss genes and associated diseases from the US National Center for Biotechnology Information. http://www.ncbi.nlm.nih.gov/disease/ Image credits U.S. Department of Energy Human Genome Program, http://www.ornl.gov/hgmis NIH Publication No. 97-3905, Understanding Gene Testing http://www.accessexcellence.org/AE/AEPC/NIH/ Cambridge Genetics Knowledge Park Document produced by Alison Stewart & Philippa Brice, Cambridge Genetics Knowledge Park. 8